Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Participants With Locally Recurrent or Metastatic Breast Cancer

ClinicalTrials.gov ID: NCT01740336

Public ClinicalTrials.gov record NCT01740336. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 6:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This multicenter, randomized, single-blind, placebo-controlled, two arm study will evaluate the efficacy and safety of paclitaxel with GDC-0941 versus paclitaxel with placebo in participants with locally recurrent or metastatic breast cancer.

Study identification

NCT ID
NCT01740336
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Genentech, Inc.
Industry
Enrollment
183 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 6, 2013 (Actual)
Primary completion
Oct 20, 2015 (Actual)
Completion
Dec 10, 2015 (Actual)
Last update posted
Apr 24, 2017

2013 – 2015

United States locations

U.S. sites
47
U.S. states
21
U.S. cities
46
Facility City State ZIP Site status
Arizona Oncology Associates, PC - NAHOA Sedona Arizona 86336 —
Pacific Cancer Medical Center Anaheim California 92801 —
California Cancer Associates for Research & Excellence, Inc. Encinitas California 92008 —
Kaiser Permanente - Hayward Hayward California 94545 —
Kaiser Permanente - Oakland Oakland California 94611 —
Bay Area Cancer Research Group, LLC Pleasant Hill California 94523 —
Kaiser Permanente Medical Center - Roseville Roseville California 95661 —
Kaiser Permanente Sacramento Medical Center Sacramento California 95825 —
Kaiser Permanente - San Francisco (2238 Geary) San Francisco California 94115 —
University of California at San Francisco San Francisco California 94115 —
Kaiser Permanente - San Jose San Jose California 95119 —
Kaiser Permanente - Santa Clara Santa Clara California 95051 —
Kaiser Permanente - South San Francisco South San Francisco California 94080 —
Kaiser Permanente - Vallejo Vallejo California 94589 —
Kaiser Permanente - Walnut Creek Walnut Creek California 94596 —
Helen & Harry Gray Cancer Center-Hartford Hospital-CCD PRIME; Research Hartford Connecticut 06102-5037 —
Clinical Research of South Florida Coral Gables Florida 33134 —
Cancer Specialists of North Florida Orange Park Florida 32073 —
Hematology - Oncology Associates of Treasure Coast Port Saint Lucie Florida 34952 —
Phoebe Putney Memorial Hospital Albany Georgia 31701 —
Joliet Oncology-Hematology; Associates, Ltd. Joliet Illinois 60435 —
Oncology Specialists, S.C. Park Ridge Illinois 60068 —
Illinois Cancer Care Peoria Illinois 61615 —
Cotton-O'Neil Clinical Research Center, Hematology and Oncology; Cotton O'Neil Cancer Center Topeka Kansas 66606 —
Hematology Oncology Clinic Baton Rouge Louisiana 70808 —
Metairie Oncologist, LLC Metairie Louisiana 70006 —
Maine Research Associates Auburn Maine 04210 —
Dana Farber Cancer Institute Boston Massachusetts 02215 —
Beth Israel Deaconess Med Ctr Brookline Massachusetts 02445 —
Henry Ford Health System Detroit Michigan 48202 —
Billings Clinic Cancer Center-CCD PRIME Billings Missouri Montana —
Nebraska Cancer Specialists; Oncology Hematology West, PC Omaha Nebraska 68130 —
ProHEALTH Care Associates LLP Lake Success New York 11042 —
Summa Health System Akron Ohio 44304 —
Aultman Hospital; Aultman Hospital Cancer Center Canton Ohio 44710 —
TriHealth Oncology Institute Cincinnati Ohio 45247 —
Abington Memorial Hospital Abington Pennsylvania 19001 —
Hematology and Oncology Associates of Sc Greenville South Carolina 29615 —
Shivers Cancer Center at University Medical Center Brackenridge Austin Texas 78701 —
Texas Oncology Bedford Texas 76022 —
Texas Oncology, P.A. - El Paso; West El Paso Texas 79902 —
Texas Oncology - Memorial City Houston Texas 77024 —
Texas Oncology, P.A. ;Sherman Cancer Center Sherman Texas 75090-0504 —
Northern Utah Associates Ogden Utah 84403 —
Shenandoah Oncology Associates Winchester Virginia 22601 —
Puget Sound Cancer Centers Edmonds Washington 98026 —
Swedish Health Services Seattle Washington 98122 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 50 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01740336, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 24, 2017 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01740336 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →